Zobrazeno 1 - 10
of 53
pro vyhledávání: '"Xingxing S. Cheng"'
Autor:
Jillian S. Caldwell, DO, Gomathy Parvathinathan, MS, Margaret R. Stedman, PhD, MPH, Patrick Ahearn, MD, MAS, Jane C. Tan, MD, PhD, Xingxing S. Cheng, MD, MS
Publikováno v:
Transplantation Direct, Vol 10, Iss 7, p e1653 (2024)
Background. Systemic barriers to posttransplant care, including access to immunosuppressant medications, contribute to higher rates of kidney transplant failure in racial minorities. Matching donor and recipient HLA alleles reduce allorecognition, ea
Externí odkaz:
https://doaj.org/article/606a35ad238f4d44ac7a24c0ecfc5014
Publikováno v:
Kidney International Reports, Vol 5, Iss 5, Pp 632-642 (2020)
Introduction: Immune-complex deposition in the transplanted kidney can present as well-phenotyped recurrent or de novo glomerular disease. However, a subset, herein termed immune-complex glomerulopathy not otherwise specified (ICG-NOS), defies classi
Externí odkaz:
https://doaj.org/article/4afd77c1527c4faf9e79458fbe8d4268
Autor:
Xingxing S. Cheng, Roy O. Mathew, Ravi Parasuraman, Ekamol Tantisattamo, Swee-Ling Levea, Rajan Kapoor, Darshana M. Dadhania, Janani Rangaswami
Publikováno v:
Kidney Medicine, Vol 2, Iss 4, Pp 505-507 (2020)
Externí odkaz:
https://doaj.org/article/33e5f0e97bb0482c8ec092dea3409ed7
Autor:
Xingxing S. Cheng, MD, Jialin Han, MS, Margaret R. Stedman, PhD, Glenn M. Chertow, MD, Jane C. Tan, PhD
Publikováno v:
Transplantation Direct, Vol 7, Iss 2, p e657 (2021)
Background. Simultaneous liver-kidney (SLK) and simultaneous heart-kidney (SHK) transplantation currently utilize 6% of deceased donor kidneys in the United States. To what extent residual kidney function accounts for apparent kidney allograft surviv
Externí odkaz:
https://doaj.org/article/b00f22749a75416780014c0ffe3caa6e
Autor:
Audrey Uffing, Maria José Pérez-Sáez, Gaetano La Manna, Giorgia Comai, Clara Fischman, Samira Farouk, Roberto Ceratti Manfro, Andrea Carla Bauer, Bruno Lichtenfels, Juliana B. Mansur, Hélio Tedesco-Silva, Gianna M. Kirsztajn, Anna Manonelles, Oriol Bestard, Miguel Carlos Riella, Silvia Regina Hokazono, Carlos Arias-Cabrales, Elias David-Neto, Carlucci Gualberto Ventura, Enver Akalin, Omar Mohammed, Eliyahu V. Khankin, Kassem Safa, Paolo Malvezzi, Michelle Marie O’Shaughnessy, Xingxing S. Cheng, Paolo Cravedi, Leonardo V. Riella
Publikováno v:
BMC Nephrology, Vol 19, Iss 1, Pp 1-8 (2018)
Abstract Background Long-term outcomes in kidney transplantation (KT) have not significantly improved during the past twenty years. Despite being a leading cause of graft failure, glomerular disease (GD) recurrence remains poorly understood, due to h
Externí odkaz:
https://doaj.org/article/8d89c5831e2349b8b1857ae208bdab1b
Autor:
Andrew A. Li, George Cholankeril, Xingxing S. Cheng, Jane C. Tan, Donghee Kim, Alice E. Toll, Satheesh Nair, Aijaz Ahmed
Publikováno v:
Diseases, Vol 6, Iss 3, p 62 (2018)
In recent years, the opioid epidemic and new hepatitis C virus (HCV) treatments have changed the landscape of organ procurement and allocation. We studied national trends in solid organ transplantation (2000–2016), focusing on graft utilization fro
Externí odkaz:
https://doaj.org/article/7e38b3d902b44aaab8fb9c8c199a9357
Autor:
Xingxing S. Cheng
Publikováno v:
JAMA Internal Medicine.
Autor:
Calyani Ganesan, Malorie Holmes, Sai Liu, Maria Montez-Rath, Simon Conti, Timothy C. Chang, Colin R. Lenihan, Xingxing S. Cheng, Glenn M. Chertow, John T. Leppert, Alan C. Pao
Publikováno v:
Clinical Journal of the American Society of Nephrology.
Publikováno v:
Am J Transplant
Increasing rates of simultaneous heart-kidney (SHK) transplant in the United States exacerbate the overall shortage of deceased donor kidneys (DDK). Current allocation policy does not impose constraints on SHK eligibility, and how best to do so remai
Autor:
John P. Roberts, Xingxing S. Cheng, John D. Scandling, Jennifer L. Bragg-Gresham, Jane C. Tan, Philip J. Held, Avi Dor, Glenn M. Chertow
Publikováno v:
American Journal of Transplantation. 21:3694-3703
A potential solution to the deceased donor organ shortage is to expand donor acceptability criteria. The procurement cost implications of using nonstandard donors is unknown. Using 5 years of US organ procurement organization (OPO) data, we built a c